Stauntoside B inhibits macrophage activation by inhibiting NF-ÎºB and ERK MAPK signalling

Article ID	Journal	Published Year	Pages	File Type
5843508	Pharmacological Research	2016	39 Pages	PDF

Keywords

mPGES-2 iNOS PGE2 MCP-1 NSAIDS IκB IFN-γ IKK TxA2 IL-1β cPGES PGI2 PGF2α mPGES-1 rps3 Inhibitory protein Cytosolic prostaglandin E synthase Prostacyclin I2 NF-κB qRT-PCR Jnk ERK PGD2 COX-2 IL-6 LPS IκB kinase MAPK interferon γ interleukin-6 Interleukin-1β Thromboxane A2 tumor necrosis factor-α Non-steroidal anti-inflammatory drugs inducible nitric oxide synthase Cyclooxygenase-2 Granulocyte colony stimulating factor G-CSF TNF-α nuclear factor-κB Anti-inflammatory activity lipopolysaccharide Nitric oxide quantitative real-time polymerase chain reaction Ribosomal protein S3 monocyte chemoattractant protein-1 Prostaglandin D2 Prostaglandin E2 Prostaglandin F2α extracellular signal-regulated kinase mitogen-activated protein kinases

Related Topics

Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmacology

Stauntoside B inhibits macrophage activation by inhibiting NF-ÎºB and ERK MAPK signalling

Authors

Jianxin Liu, Jinshan Tang, Yihan Zuo, Yang Yu, Pei Luo, Xinsheng Yao, Yan Dong, Peixun Wang, Liang Liu, Hua Zhou,